To minimise gastrointestinal side effects, the SmPC recommends gradual dose escalation
One product is approved with post-marketing data
doi:10.1016/j.mito.2020.11.010
While it has been studied for decades, it has never advanced into full pharmaceutical approval
Some protocols combine growthhormonerelated peptides with appetitemodulating agents to improve satiety, insulin sensitivity, and fat burning while preserving or increasing lean muscle mass when paired with resistance training
Slowing the ramp to the label cadence (2.5 mg start, 2.5 mg steps, four-week holds) dropped that to mid-single digits at every maintenance dose, at no cost to the 12-week result, and the dedicated slow-titration trial reached placebo range. Reaching 15 mg is not the problem